Adaptation and maladaptation of the heart in diabetes: Part I. General concepts

Circulation

Volumn 105, Issue 14, 2002, Pages 1727-1733

  Taegtmeyer, Heinrich ^a   McNulty, Patrick ^a   Young, Martin E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Heart failure

Indexed keywords

CARDIOMYOPATHY; COMORBIDITY; CONGESTIVE HEART FAILURE; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART DISEASE; HEART FAILURE; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

ADAPTATION, PHYSIOLOGICAL; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GLYCOLYSIS; HEART; HEART FAILURE, CONGESTIVE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 0037046203     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000012466.50373.E8     Document Type: Review

References (98)

1. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes
2. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
3. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
4. Coronary heart disease in the first 30 years of the 21st century: Challenges and opportunities
5. Hemodynamic actions of insulin
6. Asthma und diabetes mellitus
7. Ueber den zusammenhang des diabetes mellitus mit erkrankungen des herzens
8. Banting lecture 1988. Role of insulin resistance in human disease
9. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo study
10. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association detection project in industry study
11. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease: Chicken, egg, or neither?
12. The sex differential in mortality from all causes and ischemic heart disease
13. Insulin resistance and atherosclerosis: Common roots for two common diseases?
14. Clinical features of unrecognized myocardial infarction-silent and symptomatic. Eighteen year follow-up: The Framingham study
15. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: Assessment by exercise thallium scintigraphy
16. Studies on myocardial metabolism IV myocardial metabolism in diabetes
17. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study
18. Diabetes mellitus and congestive heart failure. Further knowledge needed
19. The diabetic heart: Metabolic causes for the development of a cardiomyopathy
20. Diabetic cardiomyopathy: A unique entity or a complication of coronary artery disease?
21. Impact of diabetes on cardiac structure and function: The strong heart study
22. The myocardial and vascular pathology of diabetic cardiomyopathy
23. Subcellular remodeling and heart dysfunction in chronic diabetes
24. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model
25. Preclinical abnormality of left ventricular function in diabetes mellitus
26. Myocardial mechanics in young adult patients with diabetes mellitus: Effects of altered load, inotropic state and dynamic exercise
27. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease
28. Gender and acute myocardial infarction: Is there a different response to thrombolysis?
29. Left ventricular regional function after acute anterior myocardial infarction in diabetic patients
30. Residual left ventricular pump function after acute myocardial infarction in NIDDM patients
31. Clinical characteristics and long-term outcome in patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: Development of a predictive model
32. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus
33. Hypertensive diabetic cardiomyopathy in the rat: Ultrastructural features
34. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy
35. Myocardial cell death in human diabetes
36. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
37. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
38. Long-term complications of diabetes mellitus
39. Science, medicine and the future. Non-insulin-dependent diabetes mellitus: The gathering storm
40. The triumvirate: β-cell, muscle cell, liver
41. The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
42. Utilization of energy providing substrates in the isolated working rat heart
43. Malonyl-CoA regulation in skeletal muscle: Its link to cell citrate and the glucose-fatty acid cycle
44. High-fat diet-induced muscle insulin resistance: Relationship to visceral fat mass
45. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats
46. Decreased insulin binding, glucose transport, and glucose metabolism in soleus muscle of rats fed a high fat diet
47. Malonyl-CoA, fuel sensing, and insulin resistance
48. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity
49. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade
50. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation
51. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase
52. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat
53. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate
54. Regulation of energy metabolism of the heart during acute increase in heart work
55. Glucose for the heart
56. Substrate metabolism as a determinant for postischemic functional recovery of the heart
57. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT 4 to the plasma membrane of cardiac myocytes
58. Alpha-adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart
59. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo
60. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis
61. Effects of ischemia and reperfusion on pyruvate dehydrogenase activity in isolated rat hearts
62. Pyruvate dehydrogenase influences postischemic heart function
63. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts
64. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts
65. The protective action of pyruvate on recovery of ischemic rat heart: Comparison with other oxidizable substrates
66. Signaling pathways in insulin action: Molecular targets of insulin action
67. Signaling aspects of insulin resistance in skeletal muscle: Mechanisms induced by lipid oversupply
68. Signaling mechanisms that regulate glucose transport
69. Expression of a constitutively active Akt ser/thre kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation
70. Roles for insulin receptor, PI3-kinase and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells
71. Pathogenesis of Niddm: A balanced overview
72. CAP defines a second signaling pathway required for insulin-stimulated glucose transport
73. The respiratory exchanges of the heart in the diabetic animal
74. What if Minkowski had been ageusic? An alternative angle on diabetes
75. Regulation of energy substrate metabolism in the diabetic heart
76. Defective energy metabolism of the heart in diabetes
77. The effects of diabetes on myocardial glucose metabolism
78. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction
79. Relationship between cardiac function and substrate oxidation in hearts of diabetic rats
80. Cellular mechanisms of insulin resistance
81. 13C nuclear magnetic resonance spectroscopy
82. 31P nuclear agenetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport and phosphorylation activity in non-insulin-dependent diabetes mellitus
83. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
84. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus
85. NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise
86. Insulin resistance characterizes glucose uptake in skeletal muscle but not the heart in NIDDM
87. Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease
88. Insulin resistance in chronic heart failure: Relation to severity and etiology of heart failure
89. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly
90. Insulin resistance in chronic heart failure
91. Insulin resistance and hyperin-sulinemia in patients with chronic congestive heart failure
92. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure
93. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure
94. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
95. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone
96. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance
97. The effects of acute and chronic diabetes on myocardial metabolism in rats